INIS
polymerases
100%
adp
100%
heart failure
100%
ribose
100%
doxorubicin
62%
inhibition
50%
endotoxins
37%
injuries
25%
mortality
25%
relaxation
25%
coronaries
25%
indium oxides
25%
oxidation
12%
mice
12%
enzymes
12%
rats
12%
data
12%
tissues
12%
aging
12%
therapy
12%
performance
12%
suppression
12%
rings
12%
injection
12%
volume
12%
cardiac output
12%
arteries
12%
Medicine and Dentistry
Heart Failure
100%
PARP Inhibitor
100%
Poly ADP Ribose Polymerase
71%
Doxorubicin
71%
Endotoxin
42%
Development
28%
Heart Function
28%
Mortality
28%
Relaxation
28%
Therapeutic Procedure
14%
Aging
14%
Cells
14%
Enzyme
14%
Oxidative Stress
14%
Tissue Injury
14%
Injection
14%
Heart Output
14%
Endothelial Dysfunction
14%
Apoplexy
14%
Experimental Therapy
14%
Ligation
14%
Diabetic Cardiomyopathy
14%
Stroke Volume
14%
Ejection Fraction
14%
Systolic Blood Pressure
14%
Heart Transplantation
14%
Left Anterior Descending Coronary Artery
14%
Heart Muscle Contractility
14%
Nitrosative Stress
14%
Heart Left Ventricle Performance
14%
Myocardial Ischemia Reperfusion Injury
14%
Coronary Artery Ligation
14%
Acute Decompensated Heart Failure
14%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
71%
Doxorubicin
71%
Endotoxin
42%
Mortality
28%
Mouse Model
14%
Tissue Injury
14%
Enzyme
14%
Rat Model
14%
Endothelial Dysfunction
14%
Diabetic Cardiomyopathy
14%
Myocardial Ischemia Reperfusion Injury
14%
Acute Heart Failure
14%
Keyphrases
Acute Myocardial Dysfunction
20%
Coronary Ligation
20%
Endothelial Remodeling
20%